Age is the leading factor in influenza vaccine selection, and vaccination remains effective well beyond the ideal September-to-October window.
|Articles|July 1, 2004
- Volume 0 0
Impotence Still Is "Taboo"
Advertisement
A recent survey of 1000 men in Great Britain revealed that 14% of British men with impotence have suicidal thoughts and wait many years before seeking help. Despite drugs to treat erectile dysfunction (ED), ~25% of the respondents said that they were too embarrassed to even discuss the problem with their wives. Also, >50% of men said that the condition caused a loss of self-confidence and self-esteem.
An estimated 2.3 million men in Britain have ED, but only 10% are being treated for the problem. Diabetes, high blood pressure, cardiovascular disease, and hormonal deficiencies can cause impotence. Medical experts have suggested that men who develop ED visit their physician to get an effective treatment and to have a routine physical examination.
Articles in this issue
over 22 years ago
Bloodstream Infection Risk Is Higher for Diabeticsover 22 years ago
Research Links Diabetes with Alzheimer'sover 22 years ago
Individuals with Chronic Pain Keep Quietover 22 years ago
Association Redesigns Web Siteover 22 years ago
Fibromyalgia Hits Individuals Differentlyover 22 years ago
Procedure May Relieve Agony of Spinal Cord Injuriesover 22 years ago
Europeans Are Slow to Seek Treatmentover 22 years ago
Intervention Curbs Asthma in Childrenover 22 years ago
Vaccine at Birth May Diminish Allergiesover 22 years ago
Asthma in Women Is Greater with Acetaminophen UseAdvertisement
Related to this article
As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.
William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.
Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.
In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.
In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge
2
Why Patients Fear Statins Will Affect Their Memory
3
Suzetrigine After Knee Replacement: Are Fewer Opioid Prescriptions Enough?
4
Orforglipron Shows CV Safety vs Insulin Glargine in ACHIEVE-4
5